10 Popular Penny Stocks on Robinhood
According to the letter acquired by CNBC from Citadel Securities' Institutional Equity Derivatives team, stocks selling below $1 per share recorded an average gain of roughly 80% in June 2020.
Cyclacel Pharmaceuticals Inc. (CYCC)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 514,780 | $1,570 | +60% | 0.01% |
| 2. | Sphera Global Healthcare Fund Doron Breen And Mori Arkin | 508,322 | $1,550 | 0.21% | |
| 3. | SilverArc Capital Devesh Gandhi | 462,659 | $1,411 | +1% | 0.58% |
| 4. | Sio Capital Michael Castor | 422,598 | $1,289 | 0.42% | |
| 5. | Point72 Asset Management Steve Cohen | 230,000 | $702 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.50 | 4,000 | Officer, Director | 4,988 | 2021-11-18 | Filing | |
| $5.00 | 1,000 | Director | 3,386 | 2021-08-24 | Filing | |
| $2.00 | 850,000 | Large Shareholder | 2,167,261 | 2017-07-19 | Filing | |
| $4.34 | 134,200 | Large Shareholder | 559,900 | 2017-02-23 | Filing | |
| $3.00 | 3,100 | Director | 3,100 | 2014-11-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.57 | 12 | Director | 3,374 | 2021-11-30 | Filing | |
| $0.51 | 650,000 | Large Shareholder | 2,806,900 | 2011-09-23 | Filing | |
| $0.60 | 500,000 | Large Shareholder | 3,456,900 | 2011-09-22 | Filing | |
| $1.80 | 50,000 | Large Shareholder | 3,956,900 | 2011-05-13 | Filing | |
| $1.73 | 100,000 | Large Shareholder | 4,006,900 | 2011-05-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 400,000 | $1,220 | 0.19% | |
| 2. | 327,269 | $998 | 0% | |
| 3. | 58,934 | $179 | 0% | |
| 4. | 43,192 | $132 | 0% | |
| 5. | 31,385 | $96 | 0.04% |
News See All
Hedge Funds Have Never Been This Bullish On Cyclacel Pharmaceuticals Inc (CYCC)
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...
5 Underperforming Stocks Targeted By Short Sellers
In this article we discuss top 5 underperforming stocks targeted by short sellers.
13D Filing: Tang Capital Partners LP and Cyclacel Pharmaceuticals Inc. (CYCC)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240...
Why Cyclacel Pharmaceuticals Inc (CYCC) is in the Spotlight
Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) shares have popped over 30% this afternoon due to momentum traders buying the stock for technical reasons.
Here’s What Is Happening In Financial Markets Today?
“Wall Street stocks on Monday were aiming to start the second quarter with tepid gains.
Here’s What Happened With Cyclacel Pharmaceuticals Inc (CYCC) And Nivalis Therapeutics Inc (NVLS)
This week was a good one for a few biotechs, but not so great for others.
Here’s Why Cyclacel Pharmaceuticals Inc (CYCC) Could Have A Rough December
Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) soared throughout the US session on Thursday, gaining as much as 60% across the day.
Movers and Shakers In Biotech: Cyclacel Pharmaceuticals Inc (CYCC) and Corium International Inc (CORI)
Yet again, we’ve had a busy start to the week in biotech. A number of companies are moving on news or data reported at the close of last week, and others on fresh information this week.
Why Are Traders Piling Into These Stocks?
Crude futures are up more than 2% this morning as weakness in the dollar and supply disturbances boost sentiment.
Billionaire Hedge Funds
